Literature DB >> 8311109

Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis.

J A Bridge1, J DeBoer, J Travis, S L Johansson, G Elmberger, S M Noel, J R Neff.   

Abstract

Cytogenetic analysis of four specimens (biopsy, definitive surgical, and two separately occurring lung metastases) of a dedifferentiated chondrosarcoma with a rhabdomyosarcomatous component revealed clonal karyotypic abnormalities in each. Anomalies seen in all specimens included a structurally aberrant chromosome 17 and extra copies of chromosomes 5, 7, 12, and 20. The derivation of the chromosomally abnormal cells was determined by a combined immunocytochemical/cytogenetic approach that allowed simultaneous assessment of cytogenetic aberrations and immunophenotypic features of individual cells. S-100 protein and desmin antibodies were used to evaluate the chondrosarcomatous and rhabdomyosarcomatous components, respectively. A chromosome 7-specific centromeric probe was used for determination of aneuploidy. In both specimens obtained from the primary lesion, S-100 protein and desmin-positive and -negative aneuploid cells were observed. These findings: 1) suggest that both the chondrocytic and rhabdomyoblastic cells arose from the same abnormal clone, 2) support the theory of a common primitive mesenchymal cell progenitor with the ability to differentiate or express features of more than one line of mesenchymal differentiation, and 3) indicate that the term dedifferentiated may be an inaccurate designation for this neoplasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311109      PMCID: PMC1887143     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

Review 1.  Interphase cytogenetic analysis in the diagnosis and study of neoplastic disorders.

Authors:  J Anastasi
Journal:  Am J Clin Pathol       Date:  1991-04       Impact factor: 2.493

2.  Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells.

Authors:  K Weber-Matthiesen; M Winkemann; A Müller-Hermelink; B Schlegelberger; W Grote
Journal:  J Histochem Cytochem       Date:  1992-02       Impact factor: 2.479

3.  Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis.

Authors:  J A Bridge; C Sreekantaiah; B Mouron; J R Neff; A A Sandberg; S R Wolman
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

4.  Dedifferentiation of low-grade chondrosarcomas.

Authors:  D C Dahlin; J W Beabout
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

5.  A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma.

Authors:  M M Zalupski; J F Ensley; J Ryan; S Selvaggi; L H Baker; S R Wolman
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

6.  Lineage-restricted clonality in biphasic solid tumors.

Authors:  J A Fletcher; G S Pinkus; N Weidner; C C Morton
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions.

Authors:  J A Bridge; P S Bhatia; J R Anderson; J R Neff
Journal:  Cancer Genet Cytogenet       Date:  1993-09
  7 in total
  6 in total

Review 1.  Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry, 'who is still afraid of red, green and blue?'.

Authors:  E J Speel; F C Ramaekers; A H Hopman
Journal:  Histochem J       Date:  1995-11

2.  Chromosomal translocation t(X;18) in human synovial sarcomas analyzed by fluorescence in situ hybridization using paraffin-embedded tissue.

Authors:  K Nagao; H Ito; H Yoshida
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

3.  Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution.

Authors:  Ruoyu Miao; Edwin Choy; Kevin A Raskin; Joseph H Schwab; Gunnlaugur Petur Nielsen; Vikram Deshpande; Ivan Chebib; Thomas F DeLaney; Francis J Hornicek; Gregory M Cote; Yen-Lin E Chen
Journal:  Sarcoma       Date:  2019-12-13

4.  Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.

Authors:  Naoko Kudo; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Wenguang Gu; Hajime Umezu; Tsuyoshi Toyama; Naoto Endo
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.535

5.  The molecular pathogenesis of dedifferentiated chondrosarcoma.

Authors:  Akio Sakamoto
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

6.  TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.

Authors:  Xiaolong Xu; Xiaodong Tang; Wei Guo; Kang Yang; Tingting Ren
Journal:  Tumour Biol       Date:  2016-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.